Medical comms - Press Releases

Date	Title	Company
14-Dec-2020	Emapalumab submission in China for primary HLH	Orphan Biovitrum AB
14-Dec-2020	Novo Holdings Creates New Rare Bleeding Disorder Company, Hemab	Novo Holdings
14-Dec-2020	Trixeo Aerosphere approved in the EU for maintenance treatment of COPD	AstraZeneca
14-Dec-2020	Celltrion Healthcare receives EU CHMP positive opinion for biosimilar adalimumab, CT-P17	Celltrion Healthcare
14-Dec-2020	Grant awarded to Qlucore to aid clinical diagnostics of cancer	Qlucore
14-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
14-Dec-2020	Freeline Reports Updated Data from Phase 1/2 B-AMAZE Trial in Hemophilia B	Freeline
14-Dec-2020	Pepscope Secures Investment to Radically Improve Development and Application of Kinase Inhibitor Therapies	Pepscope
14-Dec-2020	Calibre Scientific Enters the Canadian Market and Expands Product Portfolio With the Acquisition of Canadian Life Science	Calibre Scientific
14-Dec-2020	The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials	Russian Direct Investment Fund
10-Dec-2020	Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates	Boehringer Ingelheim
10-Dec-2020	University spin-out fund makes half a million pound first investments	Northern Accelerator
10-Dec-2020	Nokia and Vi Business partner to enable digital transformation for enterprises	Nokia
10-Dec-2020	Induction Healthcare: Half-year results	Induction Healthcare Group PLC
10-Dec-2020	European study shows: Poor health literacy a major challenge to self-care[1] with opportunity for pharmacists to play a more prominent role	GSK / GSK Consumer Healthcare
10-Dec-2020	Almac Group Granted Phase I Award Under the ‘Sustainable Innovation Fund’ to Aid COVID-19 Recovery	Almac Group
10-Dec-2020	RDIF and RCIF participate in meeting of Intergovernmental Russian-Chinese Commission for Investment Cooperation	Russian Direct Investment Fund (RDIF)
10-Dec-2020	ALUNBRIG▼(brigatinib) now available on the NHS in England, Wales and Northern Ireland for adults with ALK-positive advanced non-small cell lung cancer who have not been previously treated with an ALK inhibitor	Takeda UK Ltd
10-Dec-2020	Stats show increase in mental health drugs prescribed during pandemic	NHS Business Services Authority’s (NHSBSA)
10-Dec-2020	PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema	PureTech Health plc